Controversial FDA official leaving drug center post in latest departure at agency
Summary
Dr. Tracy Beth Høeg, the acting head of the FDA's drug review center, is leaving her position amid recent departures at the agency. Her exit follows that of FDA Commissioner Dr. Marty Makary, who resigned after disagreements over approving flavored e-cigarettes.Key Facts
- Dr. Tracy Beth Høeg led the FDA's Center for Drug Evaluation and Research (CDER) since December.
- She is stepping down shortly after Dr. Marty Makary resigned as FDA commissioner.
- Makary resigned due to conflicts over the approval of flavored e-cigarettes, which he reportedly opposed.
- Høeg has a history of vaccine skepticism, including involvement in a memo linking children's deaths to COVID-19 vaccines without data.
- Her leadership at CDER caused concern among some FDA officials.
- Dr. Vinay Prasad, former head of the vaccine approval office at the FDA, also left the agency recently.
- Høeg said she is committed to honest, science-based decision-making and transparency.
- The departures highlight internal tensions and leadership changes at the FDA.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.